COVID-KOSHA
Home
Help
(current)
Comment
!
Note: Language translations may be imperfect
A model anti-pandemic portal for scientists & public
;
High priority articles (R1, Most articles most likely to be relevant):
Second priority articles (R2, Moderate portion of articles likely to be relevant):
Other articles (R3, Lesser portion of articles likely to be relevant):
Articles Not Curated -
Drug
Last updated: 2024 Feb 18
Total hit(s): 8130
S.No.
PMID
Ascending order
Descending order
Title
Ascending order
Descending order
Journal Name
Ascending order
Descending order
Publish Date
Ascending order
Descending order
Impact Factor
Ascending order
Descending order
Citations
Ascending order
Descending order
1
38512394
Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
2
38575149
Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
3
38346223
Neutralizing antibody titers over 12 months after SARS-CoV-2 mRNA vaccine booster in patients with relapsing multiple sclerosis continuously treated with ofatumumab.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
4
38584118
Comparison of T cells mediated immunity and side effects of mRNA vaccine and conventional COVID-19 vaccines administrated in Jordan.
Hum Vaccin Immunother
2024 Dec 31
4.7
1
5
38073167
Assessing the quantity of neuropeptide Y in the serum of patients referred to Baqiyatallah Hospital with covid-19 concerning inflammatory factors following steroid therapy.
Acta Neurol Taiwan
2024 Dec 30
1
6
38086763
Development of iminosugar-based glycosidase inhibitors as drug candidates for SARS-CoV-2 virus via molecular modelling and in vitro studies.
J Enzyme Inhib Med Chem
2024 Dec
8.6
1
7
38377136
Effectiveness of a broad-spectrum bivalent mRNA vaccine against SARS-CoV-2 variants in preclinical studies.
Emerg Microbes Infect
2024 Dec
5.84
1
8
38183475
Development of multiplex allele-specific RT-qPCR assays for differentiation of SARS-CoV-2 Omicron subvariants.
Appl Microbiol Biotechnol
2024 Dec
3.82
1
9
38524302
Alternative genome sequencing approaches of SARS-CoV-2 using Ion AmpliSeq Technology.
MethodsX
2024 Jun
1
10
38574505
Diverse pro-inflammatory ability of mutated spike protein derived from variant strains of SARS-CoV-2.
Cytokine
2024 Jun
2.88
1
11
38379717
An efficient ELISA protocol for measurement of SARS-CoV-2 spike-specific IgG in human plasma and serum samples.
MethodsX
2024 Jun
1
12
38431405
Fucoidan from Ascophyllum nodosum and Undaria pinnatifida attenuate SARS-CoV-2 infection in vitro and in vivo by suppressing ACE2 and alleviating inflammation.
Carbohydr Polym
2024 May 15
6.23
1
13
38550333
Investigation of phytochemicals isolated from selected Saudi medicinal plants as natural inhibitors of SARS CoV-2 main protease: In vitro, molecular docking and simulation analysis.
Saudi Pharm J
2024 May
5.6
1
14
37929506
Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia.
Med Gas Res
2024 Apr-Jun
4
1
15
38591881
The potentiality of bacteria to drive SARS-CoV-2 mutation.
mBio
2024 Apr 9
6.5
1
16
38594459
Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infection.
Sci Rep
2024 Apr 9
4.12
1
17
38599653
Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study.
RMD Open
2024 Apr 9
6.1
1
18
38589848
Expression of the SARS-CoV-2 receptor-binding domain by live attenuated influenza vaccine virus as a strategy for designing a bivalent vaccine against COVID-19 and influenza.
Virol J
2024 Apr 9
2.45
1
19
38592189
Prediction of deleterious non-synonymous SNPs of TMPRSS2 protein combined with Molecular Dynamics Simulations and free energy analysis to identify the potential peptide substrates against SARS-CoV-2.
J Biomol Struct Dyn
2024 Apr 9
3.22
1
20
38552631
Micro-patterned culture of iPSC-derived alveolar and airway cells distinguishes SARS-CoV-2 variants.
Stem Cell Reports
2024 Apr 9
12.2
1
21
38590219
Experience of treatment in critical Guillain-Barre Syndrome case after COVID-19 vaccination.
Int J Dev Neurosci
2024 Apr 8
1
22
38587722
Analysis of SARS-CoV-2 omicron mutations that emerged during long-term replication in a lung cancer xenograft mouse model.
Virus Genes
2024 Apr 8
4.2
1
23
38438233
Mass spectrometry study on SARS-CoV-2 recombinant vaccine with comprehensive separation techniques to characterize complex heterogeneity.
Anal Chim Acta
2024 Apr 8
5.31
1
24
38589755
Dynamic Patterns and Predominance of Respiratory Pathogens Post-COVID-19: Insights from a Two-Year Analysis.
J Epidemiol Glob Health
2024 Apr 8
3.7
1
25
38593595
Eight-amino-acid sequence at the N-terminus of SARS-CoV-2 nsp1 is involved in stabilizing viral genome replication.
Virology
2024 Apr 8
2.819
1